BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38085045)

  • 21. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.
    Rajanbabu A; Agarwal R
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():77-80. PubMed ID: 29554604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
    Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW
    Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
    Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
    Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
    Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma.
    Liang S; Wang Z; Chen J; Yang X; Liang X; Sun X; Li X; Zhou R; Li Y; Wang J
    J Surg Oncol; 2021 Sep; 124(3):411-419. PubMed ID: 34086291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical re-injection of indocyanine green to improve sentinel lymph node detection in endometrial cancer.
    Maramai M; Achilarre MT; Aloisi A; Betella I; Bogliolo S; Garbi A; Maruccio M; Quatrale C; Aletti GD; Mariani A; Colombo N; Maggioni A; Multinu F; Zanagnolo V
    Gynecol Oncol; 2021 Jul; 162(1):38-42. PubMed ID: 33906784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution.
    Tucker K; Staley SA; Gehrig PA; Soper JT; Boggess JF; Ivanova A; Rossi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):346-351. PubMed ID: 31911534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
    Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
    Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel Node Biopsy in Endometrial Cancer With Dual Cervical and Fundal Indocyanine Green Injection.
    Ruiz R; Gorostidi M; Jaunarena I; Goiri C; Aguerre J; Lekuona A
    Int J Gynecol Cancer; 2018 Jan; 28(1):139-144. PubMed ID: 29194192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer.
    Buda A; Bussi B; Di Martino G; Di Lorenzo P; Palazzi S; Grassi T; Milani R
    J Minim Invasive Gynecol; 2016 Feb; 23(2):265-9. PubMed ID: 26455525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging.
    Cusimano MC; Vicus D; Pulman K; Maganti M; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Hogen LF; Covens AL; Gien LT; Kupets R; Rouzbahman M; Clarke BA; Mirkovic J; Cesari M; Turashvili G; Zia A; Ene GEV; Ferguson SE
    JAMA Surg; 2021 Feb; 156(2):157-164. PubMed ID: 33175109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indocyanine green and infrared fluorescence in detection of sentinel lymph nodes in endometrial and cervical cancer staging - a systematic review.
    Rocha A; Domínguez AM; Lécuru F; Bourdel N
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():213-219. PubMed ID: 27750179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye.
    Buda A; Crivellaro C; Elisei F; Di Martino G; Guerra L; De Ponti E; Cuzzocrea M; Giuliani D; Sina F; Magni S; Landoni C; Milani R
    Ann Surg Oncol; 2016 Jul; 23(7):2183-91. PubMed ID: 26714944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.